Home

Whistleblower Cover Story

March 8, 2011

Latest from Home

pm2409_hero854x480_automation

Cell and gene therapy manufacturing challenges to persist in 2025

CDMO 2025 Outlook

CDMO sector looks to recovery in 2025 amid positive macro, industry trends

shutterstock_424978426

Key drugs losing patent protection in 2025

pm2411_hero854x480_coverstory

Going above and beyond

With a focus on CGT manufacturing, BioForge will be operational by 2027.

Pittsburgh’s biotech leap

pm2409_hero854x480_coverstory

Pharma’s new age of longevity